icon-folder.gif   Conference Reports for NATAP  
 
 

AASLD

The Liver Meeting
Washington DC
October 2017
Back grey_arrow_rt.gif
 
 
 
Evaluation of the Safety, Pharmacokinetics, and Pharmacodynamic Effects on de Novo Lipogenesis of the Acetyl-CoA Carboxylase Inhibitor GS-0976 in Healthy Volunteers
 
 
  Reported by Jules Levin
AASLD: The Liver Meeting 2017, October 20-24, 2017, Washington, DC
 
Brian J. Kirby,1 Cara Nelson,1 Jacqueline Tarrant,1 Mona Vimal,1 Jorge Escobar,1 Qinghua Song,1 Kelvin Li,2 Marc Hellerstein,2 Bryan J. McColgan,1 C. Stephen Djedjos,1 Robert P. Myers1
1Gilead Sciences, Inc., Foster City, CA; 2University of California, Berkeley

1113171

1113172

1113173

1113174

1113175

1113176

References
1. Lawitz, E, et al. EASL 2017, oral GS-009; 2. Fullerton MD, et al. Nat Med 2013;19:1649-54; 3. Harriman G, et al. PNAS 2016;113:E1796-805; 4. Lambert JE, et al.
Gastroenterology 2014;146:726-35; 5. Bates J, et al. EASL 2017, poster FRI-352; 6. Bates J, et al. AASLD 2017, poster 2053; 7. Wei L, et al.
AASLD 2015, poster PS1938; 8. Stiede K, et al. Hepatology 2017;66:324-34; 9. Hellerstein MK, et al. Am J Physiol 1992;263:E988-1001.